NIDDK Funding Opportunity

UC4 High Impact Research and Research Infrastructure Cooperative Agreement Programs - Multi-Yr Funding

Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (UC4)

This FOA will support the conduct of advanced clinical trials designed to test the outpatient clinical safety and efficacy of artificial pancreas (AP) device systems in type 1 diabetes with the objective of improving glycemic control and reducing acute and chronic complications of the disease. These trials should generate data able to satisfy safety and efficacy requirements by regulatory agencies regarding the clinical testing of AP device systems.​

Full AnnouncementRFA-DK-14-024
Notice(s) for this Opportunity


Open Date3/15/2015
Letter of Intent Due Date

March 15, 2015​

Application Due Date
April 15, 2015, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NIDDK Program ContactGuillermo Arreaza-Rubin, M.D.

Print Page

Click outside of the light box to close the box.